188 related articles for article (PubMed ID: 33207358)
1. Potential and Clinical Significance of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment.
Yamashige D; Kawamura Y; Kobayashi M; Shindoh J; Kobayashi Y; Okubo S; Muraishi N; Kajiwara A; Iritani S; Fujiyama S; Hosaka T; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Ikeda K; Arase Y; Hashimoto M; Kumada H
Oncology; 2021; 99(3):169-176. PubMed ID: 33207358
[TBL] [Abstract][Full Text] [Related]
2. SUV max as Predictor of Metastatic Disease on 18 F-FDG PET-CT in Hepatocellular Carcinoma.
Ashfaq W; Rehman K; Shahid A; Younis MN
J Coll Physicians Surg Pak; 2024 Apr; 34(4):394-399. PubMed ID: 38576279
[TBL] [Abstract][Full Text] [Related]
3. Incidentally found parotid gland lesion in
Jung JH; Lee YS; Jung YH; Choi SH; Nam SY; Cho HJ; Kwon M
BMC Surg; 2024 Apr; 24(1):124. PubMed ID: 38658868
[TBL] [Abstract][Full Text] [Related]
4. Current Roles of Ramucirumab in the Sequential Treatment of Unresectable Hepatocellular Carcinoma.
Koizumi A; Komatsu S; Omiya S; Yano Y; Fujishima Y; Ishida J; Kido M; Gon H; Fukushima K; Urade T; So S; Yoshida T; Arai K; Fujinaka R; Shimura Y; Yanagimoto H; Toyama H; Ueda Y; Kodama Y; Fukumoto T
Anticancer Res; 2024 May; 44(5):2055-2061. PubMed ID: 38677746
[TBL] [Abstract][Full Text] [Related]
5. The added value of
Lv J; Yin H; Yu H; Shi H
Abdom Radiol (NY); 2023 Jul; 48(7):2331-2339. PubMed ID: 37119293
[TBL] [Abstract][Full Text] [Related]
6. Surgical Intervention After Lenvatinib Treatment in Patients With Advanced Hepatocellular Carcinoma.
Okuno M; Hatano E; Tada M; Nishimura T; Okamoto T; Sueoka H; Iida K; Nakamura I; Iijima H; Hirono S
Anticancer Res; 2024 Apr; 44(4):1727-1737. PubMed ID: 38537993
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET with or without CT in the diagnosis of extrahepatic metastases or local residual/recurrent hepatocellular carcinoma.
Liao X; Wei J; Li Y; Zhong J; Liu Z; Liao S; Li Q; Wei C
Medicine (Baltimore); 2018 Aug; 97(34):e11970. PubMed ID: 30142825
[TBL] [Abstract][Full Text] [Related]
8. Patlak Reconstruction Using Dynamic 18 F-FDG PET Imaging for Evaluation of Malignant Liver Tumors : A Comparison of HCC, ICC, and Metastatic Liver Tumors.
Kaneko K; Nagao M; Yamamoto A; Yano K; Honda G; Tokushige K; Sakai S
Clin Nucl Med; 2024 Feb; 49(2):116-123. PubMed ID: 38108830
[TBL] [Abstract][Full Text] [Related]
9. Role of textural analysis parameters derived from FDG PET/CT in differentiating hepatocellular carcinoma and hepatic metastases.
Ravina M; Mishra A; Kote R; Kumar A; Kashyap Y; Dasgupta S; Reddy M
Nucl Med Commun; 2023 May; 44(5):381-389. PubMed ID: 36826419
[TBL] [Abstract][Full Text] [Related]
10. Prognostic PET [
Chiu KWH; Tan KV; Yang X; Zhu X; Shi J; Chiang CL; Chan L; Hui Y; Khong PL; Man K; Wong JWH
Cancer Imaging; 2024 Mar; 24(1):42. PubMed ID: 38520026
[TBL] [Abstract][Full Text] [Related]
11. The clinical significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib and PD-1 inhibitors.
Sun W; Yin X; Liu X; Wei J; Yu M; Li W; Ding X; Chen J
Front Immunol; 2024; 15():1380477. PubMed ID: 38698848
[TBL] [Abstract][Full Text] [Related]
12. Detection of Primary Hepatocellular Carcinoma on
Arshad K; Hanan SD; Younis MN; Badar R; Imran M; Numair N; Imran A
Euroasian J Hepatogastroenterol; 2023; 13(2):66-72. PubMed ID: 38222944
[TBL] [Abstract][Full Text] [Related]
13. 18 F-FDG PET/MRI of Primary Hepatic Malignancies: Differential Diagnosis and Histologic Grading.
Sokmen BK; Inan N
Curr Med Imaging; 2024; 20():e080523216636. PubMed ID: 37157218
[TBL] [Abstract][Full Text] [Related]
14. Tuberculous Encephalitis May Be Undetectable on Magnetic Resonance Imaging but Detectable on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography.
Maramattom BV; Santhamma SGN
Am J Trop Med Hyg; 2021 Jul; 105(4):1031-1037. PubMed ID: 34310339
[TBL] [Abstract][Full Text] [Related]
15. Response Evaluation Using Contrast-Enhanced Ultrasound for Unresectable Advanced Hepatocellular Carcinoma Treated With Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy.
Zhao CK; Guan X; Pu YY; Zhou BY; Wang LF; Sun YK; Yin HH; Xia HS; Wang X; Han H; Xu HX
Ultrasound Med Biol; 2024 Jan; 50(1):142-149. PubMed ID: 37852872
[TBL] [Abstract][Full Text] [Related]
16. Complete response to the combination of Lenvatinib and Pembrolizumab in an advanced hepatocellular carcinoma patient: a case report.
Liu Z; Li X; He X; Xu Y; Wang X
BMC Cancer; 2019 Nov; 19(1):1062. PubMed ID: 31703571
[TBL] [Abstract][Full Text] [Related]
17. Association between treatment-emergent hypertension and survival with lenvatinib treatment for patients with hepatocellular carcinoma in the REFLECT study.
Piscaglia F; Ikeda K; Cheng AL; Kudo M; Ikeda M; Breder V; Ryoo BY; Mody K; Ren M; Ramji Z; Sung MW
Cancer; 2024 Apr; 130(8):1281-1291. PubMed ID: 38261521
[TBL] [Abstract][Full Text] [Related]
18.
Kirchner J; Hatzoglou V; Buthorn JB; Bossert D; Sigler AM; Reiner AS; Ulaner GA; Diamond EL
Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1154-1165. PubMed ID: 33057928
[TBL] [Abstract][Full Text] [Related]
19. Unusual Case of Primary Hepatic Squamous Carcinoma on 18F-FDG PET/CT.
Li W; Liu Z; Zhang R
Clin Nucl Med; 2023 Dec; 48(12):e596-e597. PubMed ID: 37934713
[TBL] [Abstract][Full Text] [Related]
20. The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in the Diagnosis and Evaluation of Spondylodiscitis.
Paez D; Giammarile F; Brink A; García-Pérez O; Estrada-Lobato E
Semin Nucl Med; 2024 May; 54(3):409-414. PubMed ID: 38688771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
